(Q37138988)
Statements
The pre-clinical development of MDM2 inhibitors in chronic lymphocytic leukemia uncovers a central role for p53 status in sensitivity to MDM2 inhibitor-mediated apoptosis (English)
Dale Bixby
Lisa Kujawski
scientific article published on 19 February 2008